(Q39111023)

9 September 2017

title

Heparin modulates the mitogenic activity of fibroblast growth factor by inducing dimerization of its receptor. a 3D view by using NMR. (English)

1 reference

9 September 2017

1 reference

Lidia Nieto

1

1 reference

9 September 2017

Ángeles Canales

2

1 reference

9 September 2017

Israel S Fernández

3

1 reference

9 September 2017

Elena Santillana

4

1 reference

9 September 2017

Rocío González-Corrochano

5

1 reference

9 September 2017

Mariano Redondo-Horcajo

6

1 reference

9 September 2017

F Javier Cañada

7

1 reference

9 September 2017

Pedro Nieto

8

1 reference

9 September 2017

Manuel Martín-Lomas

9

1 reference

9 September 2017

Guillermo Giménez-Gallego

10

1 reference

9 September 2017

Jesús Jiménez-Barbero

11

1 reference

9 September 2017

publication date

12 August 2013

1 reference

9 September 2017

1 reference

9 September 2017

volume

14

1 reference

9 September 2017

issue

14

1 reference

9 September 2017

page(s)

1732-1744

1 reference

Fibroblast growth factors, their receptors and signaling

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

Evolution of the Fgf and Fgfr gene families

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

Fibroblast growth factor (FGF) homologous factors share structural but not functional homology with FGFs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

Fibroblast growth factors as multifunctional signaling factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

Isolation and partial molecular characterization of pituitary fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

A unique family of endothelial cell polypeptide mitogens: the antigenic and receptor cross-reactivity of bovine endothelial cell growth factor, brain-derived acidic fibroblast growth factor, and eye-derived growth factor-II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

Purification and characterization of acidic fibroblast growth factor from bovine brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

Human brain-derived acidic and basic fibroblast growth factors: amino terminal sequences and specific mitogenic activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

Physical stabilization of acidic fibroblast growth factor by polyanions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

1H-NMR assignment and solution structure of human acidic fibroblast growth factor activated by inositol hexasulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

Structure of a heparin-linked biologically active dimer of fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

The complete amino acid sequence of human brain-derived acidic fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

Preferential self-association of basic fibroblast growth factor is stabilized by heparin during receptor dimerization and activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

Structural basis for FGF receptor dimerization and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

Myo-inositol hexasulphate and low molecular weight heparin binding to human acidic fibroblast growth factor: a calorimetric and FTIR study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

Energetics of myo-inositol hexasulfate binding to human acidic fibroblast growth factor effect of ionic strength and temperature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

Scaffold proteins: hubs for controlling the flow of cellular information

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

Gentisic acid, a compound associated with plant defense and a metabolite of aspirin, heads a new class of in vivo fibroblast growth factor inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

Tumor cell surface heparan sulfate as cryptic promoters or inhibitors of tumor growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

Structural basis for fibroblast growth factor receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

Molecular cloning, overexpression, and characterization of the ligand-binding D2 domain of fibroblast growth factor receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

Solution structure of the ligand binding domain of the fibroblast growth factor receptor: role of heparin in the activation of the receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

Conformational flexibility of a synthetic glycosylaminoglycan bound to a fibroblast growth factor. FGF-1 recognizes both the (1)C(4) and (2)S(O) conformations of a bioactive heparin-like hexasaccharide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

Solution NMR structure of a human FGF-1 monomer, activated by a hexasaccharide heparin-analogue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

Backbone dynamics of a biologically active human FGF-1 monomer, complexed to a hexasaccharide heparin-analogue, by 15N NMR relaxation methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

The activation of fibroblast growth factors by heparin: synthesis, structure, and biological activity of heparin-like oligosaccharides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

Conformational selection of the AGA*IA(M) heparin pentasaccharide when bound to the fibroblast growth factor receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

Localizing the NADP+ binding site on the MurB enzyme by NMR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

Discovering high-affinity ligands for proteins: SAR by NMR

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

Selectively desulfated heparin inhibits fibroblast growth factor-induced mitogenicity and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

Influence of heparin mimetics on assembly of the FGF.FGFR4 signaling complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

Sequence analysis of heparan sulfate epitopes with graded affinities for fibroblast growth factors 1 and 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

Structural requirements in heparin for binding and activation of FGF-1 and FGF-4 are different from that for FGF-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

Inhibition of basal FGF receptor signaling by dimeric Grb2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

Receptor specificity of the fibroblast growth factor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

Regulation by heparan sulfate in fibroblast growth factor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

Analysis of heterogeneous interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

Size-Distribution Analysis of Macromolecules by Sedimentation Velocity Ultracentrifugation and Lamm Equation Modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

N.m.r. and molecular-modelling studies of the solution conformation of heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

Fibroblast Growth Factor Receptors 1 and 2 Interact Differently with Heparin/Heparan Sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

Three-Dimensional Structure of Acidic Fibroblast Growth Factor in Solution: Effects of Binding to a Heparin Functional Analog

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

Mapping the interactions between streptococcal protein G and the Fab fragment of IgG in solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

Protamine is an inhibitor of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300313

21 January 2018

Identifiers

DOI

10.1002/CBIC.201300313

1 reference

9 September 2017

1 reference